McElwee Eliza R, Oliver Emily A, McFarling Kelli, Haney Ashley, Cuff Ryan, Head Barbara, Karanchi Harsha, Loftley Aundrea, Finneran Matthew M
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, and the Division of Endocrinology, Department of Internal Medicine, Medical University of South Carolina, Charleston, South Carolina; and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.
Obstet Gynecol. 2023 Apr 1;141(4):801-809. doi: 10.1097/AOG.0000000000005102. Epub 2023 Mar 9.
To compare stillbirth rates per week of expectant management stratified by birth weight in pregnancies complicated by gestational diabetes mellitus (GDM) or pregestational diabetes mellitus.
A national population-based retrospective cohort study of singleton, nonanomalous pregnancies complicated by pregestational diabetes or GDM was performed using national birth and death certificate data from 2014 to 2017. Stillbirth rates per 10,000 patients (stillbirth incidence at gestational age week/ongoing pregnancies-[0.5×live births at gestational age week]) were determined for each week of pregnancy from 34 to 39 completed weeks of gestation. Pregnancies were stratified by birth weight, categorized as having small-for-gestational-age (SGA), appropriate-for-gestational-age (AGA), or large-for-gestational-age (LGA) fetuses, assigned by sex-based Fenton criteria. Relative risk (RR) and 95% CI for stillbirth were calculated for each gestational age week compared with the GDM-related AGA group.
We included 834,631 pregnancies complicated by either GDM (86.9%) or pregestational diabetes (13.1%) in the analysis, with a total of 3,033 stillbirths. Stillbirth rates increased with advancing gestational age for pregnancies complicated by both GDM and pregestational diabetes regardless of birth weight. Compared with pregnancies with AGA fetuses, those with both SGA and LGA fetuses were significantly associated with an increased risk of stillbirth at all gestational ages. Ongoing pregnancies at 37 weeks of gestation complicated by pregestational diabetes with LGA or SGA fetuses had respective stillbirth rates of 64.9 and 40.1 per 10,000 patients. Pregnancies complicated by pregestational diabetes had an RR of stillbirth of 21.8 (95% CI 17.4-27.2) for LGA fetuses and 13.5 (95% CI 8.5-21.2) for SGA fetuses compared with GDM-related AGA at 37 weeks of gestation. The greatest absolute risk of stillbirth was in pregnancies complicated by pregestational diabetes at 39 weeks of gestation with LGA fetuses (97/10,000).
Pregnancies complicated by both GDM and pregestational diabetes affected by pathologic fetal growth have an increased risk of stillbirth with advancing gestational age. This risk is significantly higher with pregestational diabetes, especially pregestational diabetes with LGA fetuses.
比较妊娠期糖尿病(GDM)或孕前糖尿病合并妊娠中,按出生体重分层的期待治疗每周死产率。
利用2014年至2017年全国出生和死亡证明数据,对孕前糖尿病或GDM合并的单胎、非畸形妊娠进行基于全国人群的回顾性队列研究。确定妊娠34至39周整周中每一周每10000例患者的死产率(胎龄周的死产发生率/持续妊娠-[0.5×胎龄周的活产数])。妊娠按出生体重分层,根据基于性别的芬顿标准分为小于胎龄儿(SGA)、适于胎龄儿(AGA)或大于胎龄儿(LGA)。计算与GDM相关的AGA组相比,每个胎龄周死产的相对风险(RR)和95%可信区间(CI)。
我们在分析中纳入了834631例合并GDM(86.9%)或孕前糖尿病(13.1%)的妊娠,共有3033例死产。无论出生体重如何,GDM和孕前糖尿病合并妊娠的死产率均随胎龄增加而升高。与AGA胎儿的妊娠相比,SGA和LGA胎儿的妊娠在所有胎龄时死产风险均显著增加。妊娠37周时,孕前糖尿病合并LGA或SGA胎儿的持续妊娠每10000例患者的死产率分别为64.9和40.1。与妊娠37周时GDM相关的AGA相比,孕前糖尿病合并妊娠中LGA胎儿的死产RR为21.8(95%CI 17.4-27.2),SGA胎儿为13.5(95%CI 8.5-21.2)。死产的最大绝对风险发生在妊娠39周时孕前糖尿病合并LGA胎儿的妊娠中(97/10000)。
GDM和孕前糖尿病合并妊娠且受病理性胎儿生长影响的妊娠,随着胎龄增加死产风险升高。孕前糖尿病的这种风险显著更高,尤其是孕前糖尿病合并LGA胎儿。